Trilostane: A new treatment option for dogs with hyperadrenocorticism (1:40)

Article

"The advantage of trilostane seems to be a much higher safety profile than Lysodren with an equal efficacy rate."

Recent Videos
Philip Bergman, DVM, MS, PhD, DACVIM
Andrea Pace, CVT, VTS (ECC)
Mark J. Acierno, DVM, MBA, DACVIM
Christopher Pachel, DVM, DACVB, CABC
Richard Gerhold, DVM, MS, PhD, DACVM (Parasitology)
© 2024 MJH Life Sciences

All rights reserved.